The global syphilis treatment market is experiencing substantial growth due to increasing incidences of the disease worldwide. This phenomenon is driven by numerous factors, including shortage of access to healthcare, risky sexual practices, and ineffective public health interventions. The market comprises a broad range of medications, with bacteri